XML 52 R36.htm IDEA: XBRL DOCUMENT v3.25.3
Taxes on Earnings (Tables)
 12 Months Ended
Oct. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Domestic and Foreign Components of Earnings
The domestic and foreign components of earnings before taxes were as follows:
 For the fiscal years ended October 31
h202520242023
 In millions
U.S.$107 $537 $650 
Non-U.S.2,561 2,742 2,287 
 $2,668 $3,279 $2,937 
Schedule of (Benefit from) Provision for Taxes on Earnings
The provision for (benefit from) taxes on earnings was as follows:
For the fiscal years ended October 31
 202520242023
 In millions
U.S. federal taxes:   
Current$(188)$245 $226 
Deferred(121)34 (549)
Non-U.S. taxes:
Current328 357 337 
Deferred95 (193)(305)
State taxes:
Current(13)33 42 
Deferred38 28 (77)
 $139 $504 $(326)
Schedule of Differences Between U.S. Federal Statutory Income Tax Rate and HP's Effective Tax Rate
The differences between the U.S. federal statutory income tax rate and HP’s effective tax rate were as follows:
 For the fiscal years ended October 31
 202520242023
U.S. federal statutory income tax rate from continuing operations21.0 %21.0 %21.0 %
State income taxes, net of federal tax benefit2.4 %2.2 %1.7 %
Impact of foreign earnings including GILTI and FDII, net(2.9)%(1.0)%(1.1)%
Research and development (“R&D”) credit(2.3)%(1.1)%(1.0)%
Valuation allowances(2.5)%(7.1)%(7.3)%
Uncertain tax positions and audit settlements(10.2)%1.0 %2.4 %
Changes in tax laws or rates enacted
1.4 %0.3 %(0.3)%
Impact of internal reorganization— %— %(27.4)%
Other, net(1.7)%0.1 %0.9 %
 5.2 %15.4 %(11.1)%
Schedule of Reconciliation of Unrecognized Tax Benefits
A reconciliation of unrecognized tax benefits is as follows:
 For the fiscal years ended October 31
 202520242023
 In millions
Balance at beginning of year$1,217 $1,137 $1,045 
Increases:  
For current year’s tax positions85 82 61 
For prior years’ tax positions14 52 186 
Decreases:
For prior years’ tax positions(79)(9)(35)
Statute of limitations expirations(338)(33)(8)
Settlements with taxing authorities(34)(12)(112)
Balance at end of year$865 $1,217 $1,137 
Schedule of Significant Components of Deferred Tax Assets and Deferred Tax Liabilities The significant components of deferred tax assets and deferred tax liabilities were as follows:
 As of October 31
 20252024
 In millions
Deferred tax assets:
Loss and credit carryforwards$6,792 $7,050 
Intercompany transactions—excluding inventory208 357 
Fixed assets107 113 
Warranty81 100 
Employee and retiree benefits226 242 
Deferred revenue244 240 
Capitalized research and development1,187 1,014 
Operating lease liabilities244 272 
Investment in partnership672 710 
Other393 395 
Gross deferred tax assets10,154 10,493 
Valuation allowances(6,479)(6,688)
Total deferred tax assets3,675 3,805 
Deferred tax liabilities:
Unremitted earnings of foreign subsidiaries(36)(107)
Right-of-use assets from operating leases(211)(235)
Intangible assets(121)(159)
Cash flow hedges(5)(24)
Total deferred tax liabilities(373)(525)
Net deferred tax assets$3,302 $3,280 
Deferred tax assets and liabilities included in the Consolidated Balance Sheets as follows:
 As of October 31
 20252024
 In millions
Deferred tax assets$3,318 $3,311 
Deferred tax liabilities(16)(31)
Total$3,302 $3,280 
Schedule of Deferred Tax Assets for Net Operating Loss Carryforwards As of October 31, 2025, HP had recorded deferred tax assets for net operating loss (“NOL”) carryforwards as follows:
 Gross NOLsDeferred Taxes on NOLsValuation allowanceInitial Year of Expiration
 In millions
Federal$33 $7 $(1)2026
State1,817 97 (23)2026
Foreign24,134 6,471 (6,027)2028
Balance at end of year$25,984 $6,575 $(6,051)
Schedule of Deferred Tax Assets for Various Tax Credit Carryforwards
As of October 31, 2025, HP had recorded deferred tax assets for various tax credit carryforwards as follows:
 CarryforwardValuation
Allowance		Initial Year of Expiration
 In millions
Tax credits in state and foreign jurisdictions$307 $(61)2026
U.S. R&D and other credits52 — 2045
Balance at end of year$359 $(61) 
Schedule of Deferred Tax Asset Valuation Allowance and Changes
The deferred tax asset valuation allowance and changes were as follows:
 For the fiscal years ended October 31
 202520242023
 In millions
Balance at beginning of year$6,688 $6,994 $7,592 
Income tax (benefit) expense (230)(300)(650)
Goodwill, other comprehensive loss (income), currency translation and charges to other accounts21 (6)52 
Balance at end of year$6,479 $6,688 $6,994